Free tool
Stocks above their 200-day average
We cover 1,038 companies trading above their own 200-day average. The median market value in the group is $817.78M, measured across the 1,000 largest of them. Among those 1,000, the median move over the past trading day is 0.00%. 100% of the 1,000 with a 200-day average trade above it. Price change over the past year runs from −18.7% to +197.2% across the middle 80 percent of the group, with a median of +29.6%. Among those 1,000, 8 companies currently carry a tier A volume signal.
Other lists in this group
Table
1,038 of 10,735 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| BIAF | bioAffinity Technologies, Inc. | $5.09 | +710.51% | +317.21% | −31.59% |
| PFSA | Profusa, Inc. | $4.26 | +309.13% | −43.27% | −86.13% |
| VRAX | Virax Biolabs Group Limited | $2.77 | −4.15% | +621.35% | +365.55% |
| PHAL.ST | PharmaLundensis AB | 0.32 SEK | 0.00% | +8.19% | +37.83% |
| SHPH | Shuttle Pharmaceuticals Holdings, Inc. | $3.59 | +28.67% | +98.34% | +7.65% |
| MNDR | Mobile-health Network Solutions | $1.64 | −1.80% | +72.63% | −69.91% |
| RESP.ST | Respiratorius AB (publ) | 2.28 SEK | +3.17% | +31.03% | −39.20% |
| 27N0.DE | Cannovum Cannabis AG | 0.56 EUR | +10.76% | +24.94% | +22.47% |
| BIG1.DE | Bio-Gate AG | 2.83 EUR | −14.39% | +262.18% | +200.53% |
| SCNI | Scinai Immunotherapeutics Ltd. | $2.87 | +987.12% | +293.15% | +93.92% |
| ALINT.PA | IntegraGen SA | 0.18 EUR | −18.86% | +32.22% | −36.25% |
| APM | Aptorum Group Ltd | $8.41 | −6.45% | +685.98% | +273.78% |
| ALNEV.PA | Neovacs S.A. | 0.55 EUR | −31.22% | +6150.00% | −11.29% |
| ASCN.SW | Ascom Holding AG | 5.37 CHF | +3.47% | +46.58% | +22.28% |
| BANB.SW | Bachem Holding AG | 77.15 CHF | +4.82% | +33.69% | +21.34% |
| BION.SW | BB Biotech AG | 56.70 CHF | +8.21% | +37.62% | +84.12% |
| BSLN.SW | Basilea Pharmaceutica AG | 65.30 CHF | +24.62% | +19.82% | +40.88% |
| BTSGU | BrightSpring Health Services, Inc. | $196.47 | −17.55% | +53.75% | +142.79% |
| DOCM.SW | DocMorris AG | 10.26 CHF | −3.12% | +71.29% | +55.34% |
| GALD.SW | Galderma Group AG | 171.00 CHF | −3.44% | +7.04% | +22.58% |
| IDIA.SW | Idorsia Ltd | 5.68 CHF | −13.09% | +39.78% | +108.64% |
| IMP-A-SDB.ST | Implantica AG | 58.00 SEK | −1.69% | +12.19% | −20.44% |
| LONN.SW | Lonza Group AG | 587.80 CHF | +2.26% | +10.90% | +4.28% |
| MED.SW | Medartis Holding AG | 88.50 CHF | −1.12% | +5.11% | +0.91% |
| METN.SW | Metall Zug AG | 819.00 CHF | +4.07% | −1.80% | −13.79% |
| MOLN.SW | Molecular Partners AG | 3.41 CHF | +4.92% | +0.59% | +14.05% |
| NOVN.SW | Novartis AG | 128.34 CHF | −1.08% | +21.88% | +30.24% |
| PPGN.SW | PolyPeptide Group AG | 43.95 CHF | +0.23% | +83.13% | +57.25% |
| RO.SW | Roche Holding AG | 379.00 CHF | +1.99% | +17.47% | +41.81% |
| ROP.SW | Roche Holding AG | 373.80 CHF | +3.35% | +18.35% | +47.60% |
| SANN.SW | Santhera Pharmaceuticals Holding AG | 15.70 CHF | +9.79% | +29.32% | +13.44% |
| SDZ.SW | Sandoz Group AG | 73.54 CHF | +9.01% | +30.08% | +47.80% |
| SHLTN.SW | SHL Telemedicine Ltd. | 1.07 CHF | −0.93% | −9.32% | −32.49% |
| SKAN.SW | SKAN Group AG | 65.70 CHF | +9.87% | +26.45% | +6.80% |
| SOON.SW | Sonova Holding AG | 245.00 CHF | +10.16% | +17.62% | +6.01% |
| TECN.SW | Tecan Group AG | 193.30 CHF | +4.20% | +48.97% | +19.14% |
| VERU | Veru Inc. | $2.80 | +25.56% | +23.35% | −14.89% |
| YPSN.SW | Ypsomed Holding AG | 407.20 CHF | +4.36% | +24.15% | +4.01% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.